Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 241

1.

A multicenter investigation of fixed-dose fluoxetine in the treatment of obsessive-compulsive disorder.

Tollefson GD, Rampey AH Jr, Potvin JH, Jenike MA, Rush AJ, kominguez RA, Koran LM, Shear MK, Goodman W, Genduso LA.

Arch Gen Psychiatry. 1994 Jul;51(7):559-67. Erratum in: Arch Gen Psychiatry 1994 Nov;51(11):864.

PMID:
8031229
2.

Continuation treatment of OCD: double-blind and open-label experience with fluoxetine.

Tollefson GD, Birkett M, Koran L, Genduso L.

J Clin Psychiatry. 1994 Oct;55 Suppl:69-76; discussion 77-8.

PMID:
7961535
3.

A double-blind, placebo-controlled study of fluoxetine in patients with DSM-III-R obsessive-compulsive disorder. The Lilly European OCD Study Group.

Montgomery SA, McIntyre A, Osterheider M, Sarteschi P, Zitterl W, Zohar J, Birkett M, Wood AJ.

Eur Neuropsychopharmacol. 1993 Jun;3(2):143-52.

PMID:
8364350
4.

Sertraline and fluoxetine treatment of obsessive-compulsive disorder: results of a double-blind, 6-month treatment study.

Bergeron R, Ravindran AV, Chaput Y, Goldner E, Swinson R, van Ameringen MA, Austin C, Hadrava V.

J Clin Psychopharmacol. 2002 Apr;22(2):148-54.

PMID:
11910259
5.

Double-blind study of dextroamphetamine versus caffeine augmentation for treatment-resistant obsessive-compulsive disorder.

Koran LM, Aboujaoude E, Gamel NN.

J Clin Psychiatry. 2009 Nov;70(11):1530-5. doi: 10.4088/JCP.08m04605. Epub 2009 Jun 30.

PMID:
19573497
7.

A double-blind, placebo-controlled study of the efficacy and safety of controlled-release fluvoxamine in patients with obsessive-compulsive disorder.

Hollander E, Koran LM, Goodman WK, Greist JH, Ninan PT, Yang H, Li D, Barbato LM.

J Clin Psychiatry. 2003 Jun;64(6):640-7.

PMID:
12823077
8.

A randomized controlled clinical trial of citalopram versus fluoxetine in children and adolescents with obsessive-compulsive disorder (OCD).

Alaghband-Rad J, Hakimshooshtary M.

Eur Child Adolesc Psychiatry. 2009 Mar;18(3):131-5. doi: 10.1007/s00787-007-0634-z. Epub 2009 Feb 3.

PMID:
19190958
9.

High-dose sertraline strategy for nonresponders to acute treatment for obsessive-compulsive disorder: a multicenter double-blind trial.

Ninan PT, Koran LM, Kiev A, Davidson JR, Rasmussen SA, Zajecka JM, Robinson DG, Crits-Christoph P, Mandel FS, Austin C.

J Clin Psychiatry. 2006 Jan;67(1):15-22.

PMID:
16426083
10.

Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics.

McDougle CJ, Goodman WK, Leckman JF, Lee NC, Heninger GR, Price LH.

Arch Gen Psychiatry. 1994 Apr;51(4):302-8.

PMID:
8161290
11.

Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder.

Riddle MA, Scahill L, King RA, Hardin MT, Anderson GM, Ort SI, Smith JC, Leckman JF, Cohen DJ.

J Am Acad Child Adolesc Psychiatry. 1992 Nov;31(6):1062-9.

PMID:
1429406
12.

Citalopram for treatment-resistant obsessive-compulsive disorder.

Pallanti S, Quercioli L, Paiva RS, Koran LM.

Eur Psychiatry. 1999 Apr;14(2):101-6.

PMID:
10572334
13.

A double-blind trial of fluoxetine in pathologic skin picking.

Simeon D, Stein DJ, Gross S, Islam N, Schmeidler J, Hollander E.

J Clin Psychiatry. 1997 Aug;58(8):341-7.

PMID:
9515971
14.

[Value of fluoxetine in obsessive-compulsive disorder in the adult: review of the literature].

Etain B, Bonnet-Perrin E.

Encephale. 2001 May-Jun;27(3):280-9. Review. French.

PMID:
11488259
15.

Fluoxetine treatment for obsessive-compulsive disorder in children and adolescents: a placebo-controlled clinical trial.

Geller DA, Hoog SL, Heiligenstein JH, Ricardi RK, Tamura R, Kluszynski S, Jacobson JG; Fluoxetine Pediatric OCD Study Team..

J Am Acad Child Adolesc Psychiatry. 2001 Jul;40(7):773-9.

PMID:
11437015
16.

Efficacy of fluoxetine in Austrian patients with obsessive-compulsive disorder.

Zitterl W, Meszaros K, Hornik K, Twaroch T, Dossenbach M, Zitterl-Eglseer K, Zapotoczky HG.

Wien Klin Wochenschr. 1999 Jun 4;111(11):439-42.

PMID:
10420495
17.

Quality of life outcomes in patients with obsessive-compulsive disorder: relationship to treatment response and symptom relapse.

Hollander E, Stein DJ, Fineberg NA, Marteau F, Legault M.

J Clin Psychiatry. 2010 Jun;71(6):784-92. doi: 10.4088/JCP.09m05911blu. Epub 2010 May 4.

PMID:
20492845
18.

Fluvoxamine versus clomipramine for obsessive-compulsive disorder: a double-blind comparison.

Koran LM, McElroy SL, Davidson JR, Rasmussen SA, Hollander E, Jenike MA.

J Clin Psychopharmacol. 1996 Apr;16(2):121-9.

PMID:
8690827
19.
20.

Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with obsessive-compulsive disorder.

Greist J, Chouinard G, DuBoff E, Halaris A, Kim SW, Koran L, Liebowitz M, Lydiard RB, Rasmussen S, White K, et al.

Arch Gen Psychiatry. 1995 Apr;52(4):289-95.

PMID:
7702445

Supplemental Content

Support Center